Vium

company

About

Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare.

Details

Last Funding Type
Series B
Last Funding Money Raised
$24M
Industries
Biotechnology,Health Care,Life Science,Medical Device
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Vium, Inc.
Also Known As
Mousera

Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare. It is fully accredited by AAALAC International and received an unprecedented AAALAC commendation for upholding the 3 Rs, the gold-standard framework for humane animal research. Customers run the spectrum of biotechnology, pharmaceutical, and computational drug discovery companies to academia and novel therapeutic labs.

Vium's digital platform provides physiological biomarkers that enable better decisions on which compounds should be advanced to the clinic. The company's platform Digital Vivariumand Vium Cloud is the gold-standard in vivo platform combining computer vision, artificial intelligence, machine learning, and sensor technology to non-invasively collect and derive insights from digital biomarkers. The platform continuously captures physiological metrics and behaviors non-invasively, providing more sensitive and accurate data collection, leading to more replicable studies.

Vium was founded in 2013 and is headquartered in San Mateo, California, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$53.94M
Vium has raised a total of $53.94M in funding over 2 rounds. Their latest funding was raised on Jun 21, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 21, 2018 Series B $24M 5 DCVC
Lux Capital
Detail
Jun 9, 2015 Series A $20M 5 Detail
Oct 29, 2014 Series A $8.80M 4 Proteus Digital Health Detail
Mar 1, 2014 Seed $1.14M 2 Detail

Investors

Number of Lead Investors
Number of Investors
3
9
Vium is funded by 9 investors. DCVC and Lux Capital are the most recent investors.
Investor Name Lead Investor Funding Round
DCVC Yes Series B
Lux Capital Yes Series B
Proteus Digital Health Yes Series A
Dolby Family Ventures Series B
Founders Fund Series B
Future Shape Series B
AME Cloud Ventures Series A
Jim Greer Seed
Pathfinder Seed

Employee Profiles

Number of Employee Profiles
6
Vium has 6 current employee profiles, including Board member Peter Hebert
Board member
Board member
Executive
Executive
Executive